Over 30% Covaxin takers reported adverse events, claims BHU study

Bharat Biotech begins clinical trials of TB vaccine on adults in India

Mandaviya launches Bharat Biotech’s nasal Covid vaccine

Bharat Biotech’s intranasal COVID-19 vaccine to cost Rs 800 for private markets

Bharat Biotech’s intranasal Covid vaccine approved by govt, to be available on CO-WIN

Bharat Biotech urges Centre to include its intranasal COVID vaccine in CoWIN portal

Govt rubbishes reports on approval for Covaxin due to political pressure

Bharat Biotech evinces interest to invest in Karnataka

DCGI nod to Bharat Biotech’s intranasal Covid vaccine for restricted emergency use

Bharat Biotech seeks DCGI nod for phase 2/3 Covaxin booster trial among two to 18-year-old

SII, Bharat Biotech cut COVID vaccine prices for private hospitals to Rs 225

No impact of WHO action on Covaxin, have not supplied to any UN agency: Bharat Biotech

Bharat Biotech says Covaxin safe for booster dose against Covid

India-made Covaxin now on UK’s approved travel list

Covaxin 77.8% effective against COVID-19: Lancet study

Ideal time for booster dose for COVID vaccine is 6 months after 2nd dose: Bharat Biotech MD

‘Additional clarifications’ needed from Bharat Biotech to conduct final assessment of Covaxin: WHO

Decision on Bharat Biotech’s Covaxin EUL in October: WHO

Paediatric Covaxin: Bharat Biotech completes phase 2/3 trials

Bharat Biotech awaits feedback from WHO for Covaxin EUL

Bharat Biotech awaits feedback from WHO for Covaxin EUL

Guj: First commercial batch of Covaxin released from Bharat Biotech’s new plant

Govt panel recommends EUA to Zydus Cadila’s 3-dose COVID-19 vaccine

Bharat Biotech’s Covaxin effective against Delta Plus variant of COVID-19:Study

Bharat Biotech terminates MoU with Brazilian partners after graft allegations

Bharat Biotech commits to supply 500 Mn doses of Covaxin to Centre for immunisation programme

Decision on emergency use listing of Covaxin likely in 4-6 weeks, says WHO

Brazil suspends Bharat Biotech’s Covaxin order over graft allegations

Bharat Biotech’s pre-submission meeting for Covaxin EUL with WHO on June 23

What is the role of animal serum in making of vaccines?

Social media posts twisted facts, final product doesn’t have newborn calf serum: Centre on Covaxin

Rs 150 per Covaxin dose to Centre not sustainable in long run: Bharat Biotech

Will students administered with Covaxin be allowed to travel abroad?

Bharat Biotech’s US partner Ocugen submits ‘Master File’ to FDA on Covaxin

Latest Additions

No one has right to break law: BJP on Sambhal violence

Ullal: Auto-rickshaw accident near Konaje claims driver’s life

Congress victory in bypolls not a clean chit to CM in MUDA case: R Ashoka

IPL 2025 | Got someone who can do captaincy job: Ricky Ponting on Shreyas Iyer

Will review INDI alliance’s dismal performance in Maharashtra, says Tejashwi Yadav

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.